Literature DB >> 28626852

Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology).

Aysegul Ozakyol1.   

Abstract

Entities:  

Year:  2017        PMID： 28626852     DOI： 10.1007/s12029-017-9959-0

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  23 in total

Review 1.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

2.  Epidemiology of human aflatoxin exposures and their relationship to liver cancer.

Authors:  J D Groopman; P Scholl; J S Wang
Journal:  Prog Clin Biol Res       Date:  1996

3.  Gender disparity of hepatocellular carcinoma: the roles of sex hormones.

Authors:  Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

4.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 5.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

Review 6.  Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors.

Authors:  Chun-Jen Liu; Jia-Horng Kao
Journal:  J Chin Med Assoc       Date:  2007-04       Impact factor: 2.743

7.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

Authors:  G S Qian; R K Ross; M C Yu; J M Yuan; Y T Gao; B E Henderson; G N Wogan; J D Groopman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

Review 8.  How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature.

Authors:  Gawain A Heckley; Johan Jarl; Benedict O Asamoah; Ulf G-Gerdtham
Journal:  BMC Cancer       Date:  2011-10-13       Impact factor: 4.430

Review 9.  Challenging Role of Dietary Aflatoxin B1 Exposure and Hepatitis B Infection on Risk of Hepatocellular Carcinoma.

Authors:  Basak Kucukcakan; Zehra Hayrulai-Musliu
Journal:  Open Access Maced J Med Sci       Date:  2015-03-25

Review 10.  Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.

Authors:  Arnolfo Petruzziello; Samantha Marigliano; Giovanna Loquercio; Anna Cozzolino; Carmela Cacciapuoti
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742
View more
  59 in total

1.  Microcystin-LR in peripheral circulation worsens the prognosis partly through oxidative stress in patients with hepatocellular carcinoma.

Authors:  Feifei Lei; Xu Lei; Rugui Li; Huabing Tan
Journal:  Clin Exp Med       Date:  2019-03-12       Impact factor: 3.984

2.  Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Zhi-Wei Jian; Xi-Wen Wu; Zhen-Xin Chen; Jun-Cheng Wang; Jing-Yuan Peng; Xiang-Ming Lao
Journal:  Dig Dis Sci       Date:  2019-02-28       Impact factor: 3.199

3.  Physical Activity and the Risk of Liver Cancer: A Systematic Review and Meta-Analysis of Prospective Studies and a Bias Analysis.

Authors:  Sebastian E Baumeister; Michael F Leitzmann; Jakob Linseisen; Sabrina Schlesinger
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

4.  Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative study.

Authors:  Peng-Peng Li; Gang Huang; Ning-Yang Jia; Ze-Ya Pan; Hui Liu; Yun Yang; Cheng-Jian He; Wan Yee Lau; Ye-Fa Yang; Wei-Ping Zhou
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 7.293

5.  Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism.

Authors:  Pei-Wei Shueng; Hui-Wen Chan; Wei-Chan Lin; Deng-Yu Kuo; Hui-Yen Chuang
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

6.  Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Authors:  Mohsen Malehmir; Dominik Pfister; Suchira Gallage; Marta Szydlowska; Donato Inverso; Elena Kotsiliti; Valentina Leone; Moritz Peiseler; Bas G J Surewaard; Dominik Rath; Adnan Ali; Monika Julia Wolf; Hannah Drescher; Marc E Healy; Daniel Dauch; Daniela Kroy; Oliver Krenkel; Marlene Kohlhepp; Thomas Engleitner; Alexander Olkus; Tjeerd Sijmonsma; Julia Volz; Carsten Deppermann; David Stegner; Patrick Helbling; César Nombela-Arrieta; Anahita Rafiei; Martina Hinterleitner; Marcel Rall; Florian Baku; Oliver Borst; Caroline L Wilson; Jack Leslie; Tracy O'Connor; Christopher J Weston; Abhishek Chauhan; David H Adams; Lozan Sheriff; Ana Teijeiro; Marco Prinz; Ruzhica Bogeska; Natasha Anstee; Malte N Bongers; Mike Notohamiprodjo; Tobias Geisler; Dominic J Withers; Jerry Ware; Derek A Mann; Hellmut G Augustin; Alexandros Vegiopoulos; Michael D Milsom; Adam J Rose; Patricia F Lalor; Josep M Llovet; Roser Pinyol; Frank Tacke; Roland Rad; Matthias Matter; Nabil Djouder; Paul Kubes; Percy A Knolle; Kristian Unger; Lars Zender; Bernhard Nieswandt; Meinrad Gawaz; Achim Weber; Mathias Heikenwalder
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

7.  Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer.

Authors:  Carol Lai-Hung Cheng; Felice Hoi-Ching Tsang; Lai Wei; Mengnuo Chen; Don Wai-Ching Chin; Jialing Shen; Cheuk-Ting Law; Derek Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Commun Biol       Date:  2021-07-20

Review 8.  Recent advances in nanomaterials integrated immunosensors for food toxin detection.

Authors:  Hema Bhardwaj; Gajjala Sumana
Journal:  J Food Sci Technol       Date:  2021-02-09       Impact factor: 2.701

9.  Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study.

Authors:  Coşkun Özer Demirtaş; Tuğba Tolu; Çaglayan Keklikkıran; Osman Cavit Özdoğan; Feyza Gündüz
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

10.  Circular RNA circRHOBTB3 is downregulated in hepatocellular carcinoma and suppresses cell proliferation by inhibiting miR-18a maturation.

Authors:  Gang Hu; Shusen Zhai; Sheng Yu; Zhen Huang; Ran Gao
Journal:  Infect Agent Cancer       Date:  2021-06-29       Impact factor: 2.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.